Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Luka Stanisavljevic"'
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival. In the context of bone metastases radiotherapy, low rates of treatment close t
Externí odkaz:
https://doaj.org/article/1122d4dd8fa546bd9c25a6057b2cb311
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background This retrospective study analyzed the incidence of subsequent brain metastases after palliative radiotherapy or chemoradiation in patients with stage II/III non-small cell lung cancer (NSCLC). Risk factors for brain metastases dev
Externí odkaz:
https://doaj.org/article/de741a31c924434292a596c90fa26736
Publikováno v:
Contemporary Oncology, Vol 28, Iss 1, Pp 31-36 (2024)
Externí odkaz:
https://doaj.org/article/8a3135f21db745b59683026547659b6c
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background This study analyzed mortality after radiotherapy for bone metastases (287 courses). Endpoints such as treatment in the last month of life and death within 30, 35 and 40 days from start of radiotherapy were evaluated. Methods Diffe
Externí odkaz:
https://doaj.org/article/96e18b4084e64d83854307c72ae641b7
Autor:
Carsten Nieder, Luka Stanisavljevic, Siv Gyda Aanes, Bård Mannsåker, Ellinor Christin Haukland
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background Established prognostic models, such as the diagnosis-specific graded prognostic assessment, were not designed to specifically address very short survival. Therefore, a brain metastases-specific 30-day mortality model may be releva
Externí odkaz:
https://doaj.org/article/cb452cee49e04f038805799d7948366b
Autor:
Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological
Externí odkaz:
https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b
Publikováno v:
Anticancer Research. 43:741-747
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8f0838336a6a52e208a4f569b239710
https://doi.org/10.21873/anticanres.16213
https://doi.org/10.21873/anticanres.16213
Publikováno v:
Oncology Research and Treatment. 46:157-164
Introduction: Immune checkpoint inhibitors (ICIs) have become a mainstay of treatment for different cancer types. The purpose of this study was to evaluate patterns of care and overall survival (OS) after diagnosis of brain metastases in patients man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e7926f1bdbac4e762ef9c036c95f7bc
https://doi.org/10.1159/000529627
https://doi.org/10.1159/000529627
Publikováno v:
Scandinavian Journal of Urology
Aim/Background - The aim of this study was to evaluate the feasibility and efficacy, in terms of overall survival, of intensified upfront systemic therapy in patients with metastatic hormone-sensitive prostate cancer who lived in rural Nordland Count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2e38b47f7b47cdea95c8439398d58d
https://hdl.handle.net/11250/3058722
https://hdl.handle.net/11250/3058722
Autor:
Carsten, Nieder, Luka, Stanisavljevic
Background/Aim: The aim of this study was to analyze the survival predictions obtained from an online nomogram, originally developed in two US patient cohorts with metastatic hormone-sensitive prostate cancer, because clinical practice and survival o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c2dd8abb3f6f48639159d764c9f7db
https://hdl.handle.net/10037/28728
https://hdl.handle.net/10037/28728